BioArctic's Leqembi sales reach 32.2 billion yen
Statements (3)
- Neutral
BioArctic AB's partner Eisai reported preliminary global revenue for Leqembi in the third quarter 2026.
- Neutral
Bioarctic reported total sales of Leqembi in the third quarter amounted to 32.2 billion yen.
- Neutral
BioArctic AB's partner Eisai reported preliminary global revenue for Leqembi in the third quarter 2026.